XOMA Corporation (XOMAP) Earnings History
Annual and quarterly earnings data from 1989 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 99.3% | -140.3% | -48.5% |
| 2023 | 97.0% | -879.5% | -858.2% |
| 2022 | 95.5% | -288.9% | -283.8% |
| 2021 | 99.6% | 45.9% | 41.4% |
| 2020 | 99.4% | 42.3% | 45.3% |
Download Data
Export XOMAP earnings history in CSV or JSON format
Free sign-in required to download data
XOMA Corporation (XOMAP) Earnings Overview
As of March 4, 2026, XOMA Corporation (XOMAP) reported trailing twelve-month net income of $22M, reflecting +0.6% year-over-year growth. The company earned $1.20 per diluted share over the past four quarters, with a net profit margin of -0.5%.
Looking at the long-term picture, XOMAP's historical earnings data spans multiple years. The company achieved its highest annual net income of $16M in fiscal 2021.
XOMA Corporation maintains positive profitability with a gross margin of 1.0%, operating margin of -1.4%, and net margin of -0.5%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including RPRX ($765M net income, 0.3% margin), LGND ($49M net income, -0.0% margin), INVA ($271M net income, 0.6% margin), XOMAP has room to improve margins relative to the peer group. Compare XOMAP vs RPRX →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
36 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$14M | +66.2% | -$40M | $-1.65 | -48.5% | -140.3% |
| 2023 | -$41M | -138.7% | -$42M | $-4.04 | -858.2% | -879.5% |
| 2022 | -$17M | -208.3% | -$17M | $-1.98 | -283.8% | -288.9% |
| 2021 | $16M | +18.8% | $18M | $0.65 | 41.4% | 45.9% |
| 2020 | $13M | +770.9% | $12M | $0.78 | 45.3% | 42.3% |
| 2019 | -$2M | +85.1% | -$4M | $-0.88 | -10.8% | -21.1% |
| 2018 | -$13M | -191.4% | -$17M | $-1.18 | -251.8% | -318.1% |
| 2017 | $15M | +127.3% | $17M | $0.73 | 27.7% | 32.3% |
| 2016 | -$54M | -159.8% | -$62M | $-4.72 | -962.1% | -1106.4% |
| 2015 | -$21M | +46.2% | -$40M | $-1.82 | -37.2% | -71.6% |
See XOMAP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XOMAP Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare XOMAP vs AGIO
See how XOMAP stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is XOMAP growing earnings?
XOMAP EPS of $1.20 reflects slowing growth at +0.6%, below the 5-year CAGR of N/A. TTM net income is $22M. Expansion rate has moderated.
What are XOMAP's profit margins?
XOMA Corporation net margin is -0.5%, with operating margin at -1.4%. Below-average margins reflect competitive or cost pressures.
How consistent are XOMAP's earnings?
XOMAP earnings data spans 1989-2024. The current earnings trend is +0.6% YoY. Historical data enables comparison across business cycles.